2008年度
| NO | 分類 | 和文 ・ 英文 |
著者名 | 雑誌名 | タイトル |
|---|---|---|---|---|---|
| 1 | 総説 | 和文 | 山岡吉生. | Helicobacter Research 2008;12:284-286. | 十二指腸潰瘍の人は胃癌になりにくいのですか？ |
| 2 | 原著 | 英文 | Tabassam FH, Graham DY, Yamaoka Y. | Cell Microbiol 2008;10 (4):1008-20. | OipA plays a role in Helicobacter pylori-induced focal adhesion kinase activation and cytoskeletal re-organization. |
| 3 | 原著 | 英文 | Yamauchi K, Choi IJ, Lu H, Ogiwara H, Graham DY, Yamaoka Y. | J Immunol 2008;180 (2):1207-16. | Regulation of IL-18 in Helicobacter pylori infection. |
| 4 | 原著 | 英文 | Franco AT, Johnston E, Krishna U, Yamaoka Y, Israel DA, Nagy TA, Wroblewski LE, Piazuelo MB, Correa P, Peek RM Jr. | Cancer Res 2008;68 (2):379-87. | Regulation of gastric carcinogenesis by Helicobacter pylori virulence factors. |
| 5 | 原著 | 英文 | Ito K, Yamaoka Y, Yoffe B, Graham DY. | Digest Dis Sci 2008;53 (9):2532-40. | Disturbance of apoptosis and DNA synthesis by Helicobacter pylori infection of hepatocytes. |
| 6 | 原著 | 英文 | Ito K, Yamaoka Y, Ota H, El-Zimaity H, Graham DY. | Digest Dis Sci 2008;53 (9):2541-91. | Adherence, internalization, and persistence of Helicobacter pylori in hepatocytes. |
| 7 | 原著 | 英文 | Hisatsune J, Nakayama M, Isomoto H, Kurazono H, Mukaida N, Mukhopadhyay AK, Azuma T, Yamaoka Y, Sap J, Yamasaki E, Yahiro K, Moss J, Hirayama T. | J Immunol 2008;180 (7):5017-27. | Molecular characterization of Helicobacter pylori VacA induction of IL-8 in U937 cells reveals a prominent role for p38MAPK in activating transcription factor-2, cAMP response element binding protein, and NF-kappaB activation. |
| 8 | 原著 | 英文 | Ogiwara H, Graham DY, Yamaoka Y. | Gastroenterology 2008;134 (4):1267. | vacA i-region subtyping. |
| 9 | 原著 | 英文 | Graham DY, Lu H, Yamaoka Y. | Drugs 2008;68 (6):725-36. | Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond. |
| 10 | 原著 | 英文 | Sakai K, Kita M, Sawai N, Shiomi S, Sumida Y, Kanemasa K, Mitsufuji S, Imanishi J, Yamaoka Y. | J Infect Dis 2008;197 (12):1752-61. | Levels of interleukin-18 are markedly increased in Helicobacter pylori-infected gastric mucosa among patients with specific IL18 genotypes. |
| 11 | レター | 英文 | Jafari F, Shokrzadeh L, Dabiri H, Baghaei K, Yamaoka Y, Zojaji H, Haghazali M, Molaei M, Zali MR. | Jpn J Infect Dis 2008;61 (4):290-3. | vacA genotypes of Helicobacter pylori in relation to cagA status and clinical outcomes in Iranian populations. |
| 12 | 原著 | 英文 | Ferreira AC, Isomoto H, Moriyama M, Fujioka T, Machado JC, Yamaoka Y. | Helicobacter 2008;13 (Suppl 1):28-34. | Helicobacter and gastric malignancies. |
| 13 | 原著 | 英文 | Matsuda K, Yamauchi K, Matsumoto T, Sano K, Yamaoka Y, Ota H. | Scand J Gastroenterol 2008;43 (1):25-33. | Quantitative analysis of the effect of Helicobacter pylori on the expressions of SOX2, CDX2, MUC2, MUC5AC, MUC6, TFF1, TFF2, and TFF3 mRNAs in human gastric carcinoma cells. |
| 14 | 原著 | 英文 | Shiomi S, Toriie A, Imamura S, Konishi H, Mitsufuji S, Iwakura Y, Yamaoka Y, Ota H, Yamamoto T, Imanishi J, Kita M. | Helicobacter 2008;13 (6):518-24. | IL-17 is involved in Helicobacter pylori-induced gastric inflammatory responses in a mouse model. |
| 15 | 総説 | 英文 | Yamaoka Y. | J Med Microbiol 2008;57 (Pt 5):545-53. | Roles of the plasticity regions of Helicobacter pylori in gastroduodenal pathogenesis. |
| 16 | 総説 | 英文 | Yamaoka Y, Kato M, Asaka M. | Intern Med 2008;47 (12):1077-83. | Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains. |
| 17 | 総説 | 英文 | Yamaoka Y. | World J Gastroenterol 2008;14 (27):4265-72. | Roles of Helicobacter pylori BabA in gastroduodenal pathogenesis. |
| 18 | 著書 | 英文 | Yamaoka Y, Alm R. | Helicobacter pylori: Molecular genetics and cellular biology. Yamaoka Y, ed, Caister Academic Press, Norfolk, UK. 2008; :37-60. | Helicobacter pylori outer membrane proteins. |
| 19 | 著書 | 英文 | Yamaoka Y. | Helicobacter pylori: Molecular genetics and cellular biology. Yamaoka Y, ed, Caister Academic Press, Norfolk, UK. 2008; :1-5. | Overview. |
| 20 | 著書 | 英文 | Yamaoka Y, Graham DY, Lu H. | US Gastroenterology. Sandler R. Ed. 2008;Touch Briefings:65-67. | Should triple therapy for Helicobacter pylori be abandoned as no longer effective? |
